Immunotherapy for biliary tract cancer: Current status and perspectives

VernacularTitle:胆道癌免疫疗法的现状及展望
Author: Kui LUO ¹ ; Hang SUN ; Chuanxin WU
Author Information

1. Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
Publication Type:Research Article
Keywords: biliary tract neoplasms; immunotherapy; therapeutics
From: Journal of Clinical Hepatology 2019;35(12):2837-2840
CountryChina
Language:Chinese
Abstract: Biliary tract cancer (BTC) is rare in clinical practice and is difficult to diagnose in the early stage, and conventional treatment methods have unsatisfactory clinical effects. As a new research hotspot at present, immunotherapy has been proven to have a promising future in the treatment of a variety of cancers. At present, various immunotherapies, including immunological checkpoint inhibitors, adoptive immune cell therapy, and tumor vaccine therapy, have been applied in the clinical trials of BTC. This article briefly describes the current status and perspectives of immunotherapy in the treatment of BTC.